ALDA Pharmaceuticals Corp.

ALDA Pharmaceuticals Corp.

September 18, 2007 10:10 ET

ALDA Pharmaceuticals Appoints Cowie and Fox to "Rebrand" T36®

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 18, 2007) - ALDA Pharmaceuticals Corp. ("ALDA") (TSX VENTURE:APH) announces that Cowie and Fox Inc. has been appointed to work with Group 270 Sales & Marketing Inc. to create a new "brand" and marketing program for the Company's T36® Personal Disinfectant for the retail market. Dr. Terrance Owen, President & CEO comments, "The T36® formulation is a very powerful, safe and versatile infection control agent. We are pleased to have Cowie and Fox working with us to put this unique product into the hands of consumers through the retail chains as quickly as possible".

About Cowie and Fox Inc.

Cowie and Fox Inc. is a full-service boutique advertising agency in Vancouver, British Columbia. Their team has extensive experience developing, working with, and refreshing, Canadian and international brands such as Please Mum, Vesta Properties, Semperviva Yoga, Bootlegger and lululemon athletica. Their original on- and off-line advertising & branding initiatives have captured the attention of both the national & international press.

About Group 270 Sales & Marketing Inc.

Group 270 is a full-service sales and marketing agency specializing in bringing innovative non-prescription drugs and personal care products to Canadian consumers through national and regional pharmacy customers, such as London Drugs and Shoppers Drug Mart.

About ALDA Pharmaceuticals Corp.

ALDA is focused on the development of infection control therapeutics derived from its patent-pending T36® technology. The company trades on the TSX Venture Exchange under the symbol APH.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • ALDA Pharmaceuticals Corp.
    Terrance G. Owen, Ph.D., MBA
    President, CEO and Director
    (604) 521-8300
    ALDA Pharmaceuticals Corp. - Distribution & Sales Contact
    Peter Chen, CFO and Director
    (604) 521-8300 Ext. 3
    ALDA Pharmaceuticals Corp. - Investor Relations Contact
    Scott Young
    (604) 288-7222